Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Biocept Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 2/6
Biocept has a total shareholder equity of $290.0K and total debt of $526.0K, which brings its debt-to-equity ratio to 181.4%. Its total assets and total liabilities are $22.1M and $21.8M respectively.
Anahtar bilgiler
181.4%
Borç/özkaynak oranı
US$526.00k
Borç
Faiz karşılama oranı | n/a |
Nakit | US$6.63m |
Eşitlik | US$290.00k |
Toplam yükümlülükler | US$21.81m |
Toplam varlıklar | US$22.10m |
Son finansal sağlık güncellemeleri
Recent updates
Biocept, Inc. (NASDAQ:BIOC) Shares Fly 48% But Investors Aren't Buying For Growth
Apr 17Statutory Earnings May Not Be The Best Way To Understand Biocept's (NASDAQ:BIOC) True Position
Nov 23Just In: One Analyst Has Become A Lot More Bullish On Biocept, Inc.'s (NASDAQ:BIOC) Earnings
Aug 19Shareholders Will Probably Hold Off On Increasing Biocept, Inc.'s (NASDAQ:BIOC) CEO Compensation For The Time Being
Jul 03Biocept and CLEARED4 ink collaboration agreement
Jun 09Biocept enters COVID-19 testing partnership
Apr 28Biocept (NASDAQ:BIOC) Shareholders Have Enjoyed An Impressive 104% Share Price Gain
Mar 13We're Keeping An Eye On Biocept's (NASDAQ:BIOC) Cash Burn Rate
Jan 26Biocept, Inc. (NASDAQ:BIOC): Is Breakeven Near?
Dec 22Biocept's assays viable and sensitive for detecting tumor cells and biomarkers
Nov 20Biocept +4% on COVID-19 testing update
Nov 12Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: BIOC's short term assets ($8.9M) exceed its short term liabilities ($4.9M).
Uzun Vadeli Yükümlülükler: BIOC's short term assets ($8.9M) do not cover its long term liabilities ($16.9M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: BIOC has more cash than its total debt.
Borcun Azaltılması: BIOC's debt to equity ratio has increased from 20% to 181.4% over the past 5 years.
Bilanço
Nakit Pist Analizi
Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.
İstikrarlı Nakit Pisti: BIOC has less than a year of cash runway based on its current free cash flow.
Tahmini Nakit Akışı: BIOC has less than a year of cash runway if free cash flow continues to grow at historical rates of 15.3% each year.